These 3 Patient Advocacy Groups Are Helping Solve Issues in the COVID-19 PandemicThe Motley Fool • 07/12/20
Bristol Myers (BMY) Moves to Strong Buy: Rationale Behind the UpgradeZacks Investment Research • 07/09/20
Bristol Myers Just Launched A New MS Drug — But Is BMY Stock A Buy?Investors Business Daily • 07/08/20
Bristol Myers Squibb: Insider Anticipating Significant Shareholder Value Creation From MergerSeeking Alpha • 07/02/20
Q2 Earnings Will Be Gruesome and COVID Is Back: Rotate to Defensive Dividend Stocks24/7 Wall Street • 07/02/20
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Special Call (Transcript)Seeking Alpha • 06/26/20
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Hosts Investor Series - Hematology Conference Call (Transcript)Seeking Alpha • 06/26/20
Bristol Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy? (Revised)Zacks Investment Research • 06/23/20